AAPM Opioid Advisory Committee member Halena Gazelka, MD, testified as a witness at a February 12 U.S. Senate hearing on Pain Management in the Opioid Crisis before the HELP Committee. View video of the hearing and Dr. G...
Content in this section will include AAPM advocacy efforts, legislative news, public statements, etc.
"AAPM is happy to endorse measures such as this one that will support physicians' work towards better pain management therapies. If passed, this bill will provide protections to the Academy's members working in the VA sy...
The NAM webinar will introduce the Action Collaborative on Countering the U.S. Opioid Epidemic, which comprises government, communities, health systems, provider groups, payers, industry, nonprofits, academia, and more. ...
To encourage drug companies to enter the OTC market and increase access to naloxone, the FDA took an unprecedented step of developing a model Drug Facts label (DFL) with easy-to-understand pictograms on how to use the dr...
The American Medical Association (AMA), Colorado Medical Society (CMS) and Manatt Health released a report today that shows Colorado has implemented meaningful reforms in response to the opioid epidemic though further st...
NASEM will host two public workshops to gather information and guide its work in drafting clinical practice guidelines for prescribing opioids for acute pain. Register for the first webinar on February 4th .
The HHS Pain Management Best Practices Inter-Agency Task Force has released a draft report calling for individualized, patient-centered pain management to improve the lives of millions of individuals who experience acute...
An advisory panel to the U.S. Food and Drug Administration recommended prescribing the opioid overdose reversal drug, naloxone, with addictive painkilllers. Full story .
The American Medical Association (AMA), Pennsylvania Medical Society (PAMED) and Manatt Health released the first in a series of studies of state responses to the opioid epidemic. Full story .
Federal and state government efforts to reduce prescription opioids are inadvertently harming chronic pain patients in the United States, Human Rights Watch said in a new report. Full Story .